Information  X 
Enter a valid email address

Ergomed plc (ERGO)

  Print   

Tuesday 23 November, 2021

Ergomed plc

Holdings in Company

RNS Number : 3062T
Ergomed plc
23 November 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7ZCY67

Issuer Name

ERGOMED PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Aggregate of abrdn plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

18-Nov-2021

6. Date on which Issuer notified

22-Nov-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

11.419019

0.000000

11.419019

5,608,694

Position of previous notification (if applicable)

11.376066

0.000000

11.376066


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7ZCY67


5,608,694


11.419019

Sub Total 8.A

5,608,694

11.419019

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights






Sub Total 8.B1




8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights







Sub Total 8.B2




9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

abrdn plc





abrdn plc

Standard Life Investments (Holdings) Limited




abrdn plc

Standard Life Investments Limited

9.531419

0.000000

9.531419%






abrdn plc





abrdn plc

Standard Life Investments (Holdings) Limited




abrdn plc

Ignis Asset Management Limited




abrdn plc

Ignis Investment Services Limited









abrdn plc





abrdn plc

Aberdeen Asset Management PLC




abrdn plc

Aberdeen Asset Managers Limited









abrdn plc





abrdn plc

Standard Life Investments (Holdings) Limited




abrdn plc

abrdn Capital Limited




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

In reference to section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

This disclosure is to reflect the fact that the voting rights held by the underlying investment management entity Standard Life Investments Limited ("SLIL") decreased below the 10% notifiable threshold due to an internal inspecie transfer on 18th November 2021. SLIL now holds the delegated voting rights to 9.531419% of the shares in Ergomed plc. Previously SLIL held the delegated voting rights to 10.971776% of the shares.

12. Date of Completion

22-Nov-2021

13. Place Of Completion

Edinburgh, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBJBJTMTMTBFB

a d v e r t i s e m e n t